
Intra-operative IV Iron Isomaltoside Prevents Post-Op Anemia in Patients Undergoing TKA

Intra-operative IV Iron Isomaltoside Prevents Post-Op Anemia in Patients Undergoing TKA
Efficacy of intra-operative administration of iron isomaltoside for preventing postoperative anaemia after total knee arthroplasty: A randomised controlled trial
Eur J Anaesthesiol. 2021 Apr 1;38(4): 358-365.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
One hundred patients scheduled for a total knee arthroplasty were randomized to receive intra-operative iron isomaltoside (n=50) or placebo (n=50) for the prevention of post-operative anemia. The primary outcome of interest was the incidence of anemia at 30 days post-operation. Secondary outcomes of interest included hemoglobin (Hb) levels, iron panels, post-operative transfusion rate, length of s...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Learn about our AI Driven
High Impact Search Feature

The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.